- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06014281
Examinando os efeitos da prática regular de meditação breve baseada na Internet na saúde mental e no bem-estar
Um ensaio de controle randomizado administrado pela Internet para examinar os efeitos da prática regular e breve de meditação na saúde mental e no bem-estar
The study will examine the effects of online meditation training on stress and anxiety in healthy participants. It will also examine the dose-response relationship between the amount of daily focused attention meditation practice and established mental health outcome measures.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This is a 16-week study with an 8-week meditation intervention, with a requirement of a minimum of 10 minutes of meditation practice each day. This study will recruit ~200 healthy subjects (18+ years) with no current or previous diagnosis of psychiatric or neurological disorders who are interested in learning about meditation but don't have long-term experience with meditation. Half of the participant pool will be randomly assigned to the meditation intervention, and the other half will get the wait-list control assignment. The control group will later receive its intervention, likely a few weeks after the completion of the active group's intervention. A focused-attention meditation technique (SOS meditation) will be used to train participants.
Changes in participants' physiological markers (e.g., HRV, physical activity, respiration rate, sleep quality) will be evaluated using passive activity monitoring devices (e.g., Fitbit). Intervention-related changes in mental health will be assessed using web-based mental health and well-being surveys. Improvements in cognitive functioning will be assessed using web-based psychological tasks.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
Stanford, California, Estados Unidos, 94305
- Dept. of Psychiatry, Stanford University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age ≥ 18 years
- Able to follow basic instructions for prescreening and scheduling
- Compliant with investigator instructions during the consent process and participation in the study
- Is not already a regular meditation practitioner
Exclusion Criteria:
- Age <18
- People with a current diagnosis of psychiatric or neurological disorders
- Be in current psychiatric treatment or medications
- Hospitalized for psychiatric disorders in the past year or so.
- Regular and long-term meditation practitioners
- Non-English speaking
- Non-USA mailing address to receive the activity tracker device
- Vision or hearing impairment severe enough to interfere with study participation
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Meditation group
Baseline to week 8: Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed. Week 8 to week 16: Subjects will self report if they choose to continue SOS meditation and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the impact of continued meditation practice on mental health and well being. |
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions:
|
|
Experimental: Waitlist control
Baseline to week 8: Subjects will be place in a control group which receives no intervention. However, several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess baseline mental health and well being scores. Week 8 to week 16: Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed. |
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Generalize Anxiety Disorder Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Anxiety as measured using Generalize Anxiety Disorder Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Pittsburgh Sleep Quality Index Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Sleep Quality measured using Pittsburgh sleep quality index (PSQI) |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Mind Wandering Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Mind wandering measured using the Mind Wandering Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Resting Heart Rate
Prazo: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
|
Heart Rate Variability
Prazo: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
|
Change in Stroop Test Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Using the Stroop test, which measures the average reaction time between incongruent and congruent trials |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in N-back Test Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Using the N-back test is a memory task where participants must remember letters from N trials ago. |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Stress Scale Measure Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Stress measured using Perceived Stress Scale measure |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Depression Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Depression measured using Patient Health Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Quality of Life Scale Measures Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Quality of life measured using Quality of Life Scale measures |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change Social Connectedness Scale-Revised Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Social Connectedness measured using Social Connectedness Scale-Revised |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Rumination Reflection Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Rumination and reflection scales measured using Rumination Reflection Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Brief Strengths Scale Questionnaire Score
Prazo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Strengths scale measured using Brief Strengths Scale measures individuals' Temperance Strength, Intellectual Strength, and Interpersonal Strength. |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Sleep Quality Measure
Prazo: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Manish Saggar, PhD, Stanford University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 68784
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .